Skip to main content
Close
Providing Answers, Support and Hope in Texas
This is my chapter   |   
Reset

Cornonavirus Updates

April 8, 2020 - The Lupus Foundation of America has been working to address the shortage of hydroxychloroquine for lupus patients. In addition to advocating for people with lupus to state and federal governmentsstate boards of pharmacy, and drug manufacturers, we have been working to identify pharmacies that have supplies of hydroxychloroquine that can be accessed by people with lupus.CONTINUE READING

April 8, 2020 - We are proud to support the Global Rheumatology Alliance’s COVID-19 Registry. This important international effort will collect de-identified information from clinicians and people with rheumatic diseases, such as lupus. Currently, little is known about the coronavirus (COVID-19) and how it impacts people with rheumatic diseases. The information collected in the registry will help evaluate the risk of COVID-19 among people with rheumatologic disease and provide information that will help improve the way doctors manage and treat rheumatic patients during this time. CONTINUE READING

April 4, 2020 - There is no evidence that taking hydroxychloroquine (Plaquenil) is effective in preventing a person from contracting the coronavirus (COVID-19). People with lupus should follow the guidance of their doctor and the safety guidelines being issued by the CDC.CONTINUE READING

April 1, 2020 - New resource: Tips on what to do if you have a prescription for hydroxychloroquine or chloroquine and are experiencing difficulties getting your prescription filled.. 


See All Updates

April 8, 2020 - The Lupus Foundation of America has been working to address the shortage of hydroxychloroquine for lupus patients. In addition to advocating for people with lupus to state and federal governmentsstate boards of pharmacy, and drug manufacturers, we have been working to identify pharmacies that have supplies of hydroxychloroquine that can be accessed by people with lupus.CONTINUE READING

April 8, 2020 - We are proud to support the Global Rheumatology Alliance’s COVID-19 Registry. This important international effort will collect de-identified information from clinicians and people with rheumatic diseases, such as lupus. Currently, little is known about the coronavirus (COVID-19) and how it impacts people with rheumatic diseases. The information collected in the registry will help evaluate the risk of COVID-19 among people with rheumatologic disease and provide information that will help improve the way doctors manage and treat rheumatic patients during this time. CONTINUE READING

April 4, 2020 - There is no evidence that taking hydroxychloroquine (Plaquenil) is effective in preventing a person from contracting the coronavirus (COVID-19). People with lupus should follow the guidance of their doctor and the safety guidelines being issued by the CDC.CONTINUE READING

April 1, 2020 - New resource: Tips on what to do if you have a prescription for hydroxychloroquine or chloroquine and are experiencing difficulties getting your prescription filled.. 

March 30, 2020 - FDA issues emergency authorization of hydroxychloroquine amid coronavirus pandemic. READ STATEMENT

March 23, 2020 - the Lupus Foundation of America issued a joint statement with the American College of Rheumatology, the American Academy of Dermatology, and the Arthritis Foundation to the White House Coronavirus Task Force, the leadership of the U.S. Congress and the nation’s governors urging them to take action and ensure people with lupus have access to hydroxychloroquine (Plaquenil) and chloroquine. READ STATEMENT

March 23, 2020 - Lupus Foundation of America Urges Manufacturers of Hydroxychloroquine and Chloroquine to Ensure Supply to Treat Lupus. CONTINUE READING

March 17, 2020 - The CDC has recommended that people with serious underlying health conditions stay home and avoid other people as much as possible through March 30, 2020. Lupus is a serious underlying health condition that could lead to a compromised immune system. 

Please see Appendix A (on page 10) in this document from the CDC for a more detailed explanation of underlying health conditions that may increase the risk of serious illness from coronavirus.

March 11, 2020 - Effective today, the Lupus Foundation of America, Lone Star Chapter, as a responsible health agency caring for those affected by lupus, we have concluded that it's our responsibility to postpone all in-person programs and events for the next two months. This includes support groups, Walk to End Lupus Now™ in San Antonio and Dallas/Fort Worth, and the Rally for Lupus Annual Conference.CONTINUE READING